Application 076307

Type
ANDA
Sponsor
ACTAVIS LABS FL INC

Application Products#

Product, Drug, Ingredient table
ProductDrugIngredientFormStrengthReference drugReference standard
001MIRTAZAPINEMIRTAZAPINETABLET, ORALLY DISINTEGRATING;ORAL15MGNoNo
002MIRTAZAPINEMIRTAZAPINETABLET, ORALLY DISINTEGRATING;ORAL30MGNoNo
003MIRTAZAPINEMIRTAZAPINETABLET, ORALLY DISINTEGRATING;ORAL45MGNoNo

NDC Listings For This Application#

NDC, Name, Nonproprietary name table
NDCNameNonproprietary nameLabelerMarketing categoryStatus
0115-1653MirtazapineMirtazapineAmneal Pharmaceuticals of New York LLCANDACurrent
0115-1653MirtazapineMirtazapineImpax GenericsANDACurrent
0115-1654MirtazapineMirtazapineAmneal Pharmaceuticals of New York LLCANDACurrent
0115-1654MirtazapineMirtazapineImpax GenericsANDACurrent
0115-1656MirtazapineMirtazapineAmneal Pharmaceuticals of New York LLCANDACurrent
0115-1656MirtazapineMirtazapineImpax GenericsANDACurrent
0591-2470MirtazapineMirtazapineActavis Pharma, Inc.ANDACurrent
71335-0951MirtazapineMirtazapineBryant Ranch PrepackANDACurrent
71335-0951MirtazapineMirtazapineBryant Ranch PrepackANDACurrent

Documents#

Document, Submission type, Date table
DocumentSubmission typeDate
23815ORIG2005-08-01